Build and Edit
Generate wild-type, overexpression, or silencing constructs for LAMC1, or introduce variants by gene editing and gene knockout in a defined cell background.
LAMC1 encodes the gamma-1 chain of laminin, a widely expressed extracellular matrix protein involved in basement membrane assembly. Its overexpression correlates with poor prognosis in several cancers. Creative Biolabs supports gene-function validation, disease modeling, and vector design for LAMC1-associated disease research.
Abnormal LAMC1 expression can disrupt basement membrane integrity, alter extracellular matrix remodeling, and affect cell adhesion, migration, and survival. LAMC1 overexpression has been linked to increased tumor cell proliferation, invasion, metastasis, and poor prognosis in cancers such as hepatocellular carcinoma, gastric cancer, and meningioma. Conversely, LAMC1 deficiency can impair basement membrane formation and normal tissue development.
Creative Biolabs provides research services — from gene editing and disease modeling to vector design — that help teams interrogate LAMC1 gene function and disease-relevant phenotypes.
The table below summarizes the standard gene identity and its normal expression. Distinguishing established functions from inferred ones is essential when interpreting expression changes and designing validation experiments.
LAMC1 overexpression and functional roles have been reported in several cancers. Each module below summarizes the reported association, its supporting evidence, and its limitations. Associations are not presented as causal certainty, and this page does not provide diagnostic or treatment advice.
Candidate approaches range from cancer cell lines to organoids and animal models. Each model answers a different question and carries its own readouts and limitations.
A complete validation program moves from construct generation through expression, phenotype, and rescue experiments to data interpretation. Each step produces its own evidence and should not be skipped or conflated.
Generate wild-type, overexpression, or silencing constructs for LAMC1, or introduce variants by gene editing and gene knockout in a defined cell background.
Confirm transcript and protein levels and extracellular matrix localization to ensure the construct is actually expressed and secreted rather than degraded.
Quantify migration, invasion, adhesion, and metabolic readouts to detect functional consequences of LAMC1 modulation relative to control.
In organoid or animal models, score tumor growth, metastasis, and pre-metastatic niche formation where the model supports them.
Restore LAMC1 expression to test whether the phenotype is rescued, distinguishing modulation causality from off-target or background effects.
Compare against positive and negative controls, account for experimental replicates, and state the model-specific limits before drawing conclusions about expression-disease relationships.
The services below bridge gene editing, model development, vector design, and functional assays. Each entry indicates the typical input and the deliverable; scope, timing, and feasibility are confirmed case by case.
Gene-disease associations should be read as research findings, not causal certainties. Several factors affect how confidently expression changes can be linked to a phenotype.
LAMC1 overexpression correlations require functional evidence, rescue experiments, and independent replication before a causal role can be claimed.
Prognostic correlations in HCC, meningioma, and uterine carcinoma reflect reported associations; mechanisms such as the Warburg effect are separate functional findings.
LAMC1 has both developmental roles (basement membrane assembly) and oncogenic roles. These are distinct biological contexts and should not be conflated.
Cell lines, organoids, and animal models differ in tumor microenvironment and species biology. Extrapolation to human disease requires caution.
LAMC1 fragments in serum and urine are research markers of remodeling and fibrosis, not validated clinical diagnostics.
This page is for research use only. It does not provide diagnostic, prognostic, or therapeutic recommendations.
Authoritative sources anchor the gene identity, function, and disease associations described on this page. Key facts are cited close to the relevant claim; review dates are noted where information may change.
OMIM entry for LAMC1 (laminin subunit gamma 1), documenting the gene and its role in basement membrane assembly.
View OMIM entryUniProt reference for the laminin gamma-1 chain, including its role in cell adhesion and extracellular matrix assembly.
View UniProt entryCreative Biolabs can support LAMC1-associated disease research through gene editing, model development, vector production, and functional characterization. The services below map to the validation steps described on this page.
Introduce LAMC1 knockout, overexpression, or silencing in cancer cell lines, then confirm the modification by sequencing. Edited clones provide a controlled background for functional comparison.
Build tumor-relevant models using disease-modeling gene editing and CRISPR-assisted cell line development, with baseline characterization for downstream phenotypic assays.
Design and produce expression vectors for LAMC1 knockdown or overexpression, with titer and characterization data to support transduction studies.
Quantify migration, invasion, adhesion, and metabolic readouts to test LAMC1 modulation consequences in the chosen model, with appropriate controls and replicates.
Selected Reading
Smyth N, Vatansever HS, Murray P, et al. Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation. J Cell Biol. 1999;144(1):151-160. https://doi.org/10.1083/jcb.144.1.151.
Hohenester E, Yurchenco PD. Laminins in basement membrane assembly. Cell Adh Migr. 2013;7(1):56-63. https://doi.org/10.4161/cam.21831.
Fang Y, Dou R, Huang S, et al. LAMC1-mediated preadipocytes differentiation promoted peritoneum pre-metastatic niche formation and gastric cancer metastasis. Int J Biol Sci. 2022;18(7):3082-3101. https://doi.org/10.7150/ijbs.70524.
Ye G, Qin Y, Wang S, et al. Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway. Cancer Biol Ther. 2019;20(5):711-719. https://doi.org/10.1080/15384047.2018.1564558.
Ke HL, Ke RH, Li B, et al. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival. Acta Neurochir (Wien). 2013;155(1):165-171. https://doi.org/10.1007/s00701-012-1512-0.
Selected sources cover LAMC1 gene identity, function, and disease associations. Last verified November 2026. Clinical-stage information changes over time and is not provided on this page.
Direct answers about gene function, disease association, validation models, and interpretation of experimental findings.
LAMC1 encodes the gamma-1 chain of laminin, the most widely expressed laminin chain. It assembles basement membranes and regulates cell adhesion, differentiation, signal transduction, and tissue development.
LAMC1 overexpression is reported to correlate with poor prognosis in hepatocellular carcinoma and meningioma, with uterine carcinoma progression, and with increased peritoneal metastasis risk. These are reported associations requiring independent validation.
Options include cancer cell lines, tumor organoids, and mouse models of metastasis. Each answers a different question — from migration and invasion readouts to metastatic niche formation — and carries its own limitations.
Establishing a causal role requires functional evidence, rescue experiments, and independent replication. Correlation alone does not prove causation, and gene-disease links should be read as research findings.
Creative Biolabs supports gene editing, disease modeling, vector design, and functional assays for LAMC1-associated disease research. Scope, inputs, and deliverables are confirmed case by case with our scientific team.
No. This page is provided for research use only and does not offer diagnostic, prognostic, or therapeutic recommendations. Clinical questions should be directed to qualified healthcare professionals.
Tell us about your project, and our experts will get back to you with a customized quote and proposal.